4//SEC Filing
Weissman James B 4
Accession 0001399529-21-000078
CIK 0001399529other
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 7:17 PM ET
Size
5.3 KB
Accession
0001399529-21-000078
Insider Transaction Report
Form 4
Weissman James B
Chief Business Officer
Transactions
- Sale
Common Stock
2021-04-16$29.99/sh−4,904$147,071→ 16,000 total
Footnotes (2)
- [F1]The Reporting Person sold an aggregate of 4,904 shares of Common Stock on April 16, 2021 (the "Shares Sold") as reported in this Form 4. The Shares Sold represent 0.61% of 799,032 shares of Common Stock, which is the number of shares of Common Stock owned by the Reporting Person prior to the Shares Sold transaction reported in this Form 4, as well as shares issuable upon exercise or settlement of vested and unvested options and restricted stock units held by the Reporting Person as of the date of this report.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2020.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
Related Parties
1- filerCIK 0001598480
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 7:17 PM ET
- Size
- 5.3 KB